Update From OASAS Where are we and where are we going? Steven Kipnis MD, FACP, FASAM Medical Director, NYS OASAS

Size: px
Start display at page:

Download "Update From OASAS Where are we and where are we going? Steven Kipnis MD, FACP, FASAM Medical Director, NYS OASAS"

Transcription

1 Update From OASAS Where are we and where are we going? Steven Kipnis MD, FACP, FASAM Medical Director, NYS OASAS

2 Prescription drug misuse remains a critical and pervasive health concern that poses unique challenges because of the need to balance prevention, education, and enforcement, with the need for legitimate access to scheduled medications and the protection of patient care.

3 2011 Expanding on the Office of National Drug Control Policy (ONDCP) plan, OASAS put together active workgroups in the following areas: public education, prescriber education, monitoring, medication disposal, enforcement, overdose prevention, treatment access, adolescent issues/prevention, and outcomes.

4 What we Delivered Rx Misuse Website Medication disposal policy Medication Drop Box grant Guidance for physicians on when to consult Guidance for physicians on interpreting the UDS Medicine Cabinet inventory sheet Palm Cards for Pharmacists

5 NYS DROP BOX LOCATIONS

6

7

8 I-STOP With the passage of the I-STOP legislation, the workgroups were merged so as to guide NYSDOH. Lead by OASAS staff, the Public Awareness workgroup and the Continuing Education Workgroup were formed. o o Public Awareness issued numerous educational pieces for parents, schools and prescribers. The Continuing Education Workgroup made recommendations for prescriber and pharmacist education and prescribing guidelines.

9 SafeMedNY Brochures Produced Prescription Drug Misuse... A Household Problem Prescription Safety How to Know...I think my child is using alcohol and/or drugs Medicine Cabinet Inventory Protect Your Children: Information for Parents Stop Prescription Pain, Medication Misuse

10 Where are we now?

11 Prescription Drug Abuse: Strategies to Stop the Epidemic 2013 report released by The Trust for America s Health New York s summary is: o New York has the sixth lowest drug overdose mortality rate in the United States, with 7.8 per 100,000 people suffering drug overdose fatalities o The report also finds that New York received nine out of 10 possible indicators of promising strategies to help curb prescription drug abuse. Nationally, 28 states and Washington, D.C. scored six or less New Mexico and Vermont scoring the highest, with a 10 South Dakota scoring the lowest with two out of 10

12 Admissions to NYS OASAS Certified Chemical Dependence Programs by Primary Substance and Age Group, CY Prescription opiates admissions increased from 9,969 in 2007 to 23,913 in 2012, a 140% increase. Prescription opiates admissions increased for all age groups between 2007 and The greatest percent increases during that period were among year olds (214%) and year olds (214%). Prescription opiates admissions are admissions where the primary substance at admission was OxyContin or another synthetic opiate.

13 Heroin admissions increased from 57,320 in 2007 to 61,583 in 2012, a 7% increase. The greatest percent increase during that period was 85% among year olds. There was a 30% decrease in heroin admissions by year olds. Heroin admissions are admissions where heroin was the primary substance at admission.

14 Regulatory Flexibility To ensure that existing beds are utilized Such flexibility is important for two initiatives: o Ancillary Withdrawal Services Has allowed our outpatient programs to provide mild to moderate withdrawal (detox) services. This authority has not only increased our state-wide capacity to provide outpatient withdrawal services, but has also allowed for better engagement in continuing with outpatient treatment after the withdrawal services.

15 Regulatory Flexibility Swing Beds o o We are allowing providers who offer multiple levels of detox services to utilize their treatment beds as a combined program OASAS authorized Alcohol and Drug Dependency Services in Buffalo as the first provider in this model and we will look to expand this model. The project has proceeded without incident. Patients transition easily through levels of care. Patient care is improved due to expanded and flexible medication availability. No patients have been turned away due to lack of capacity in either level. The program has seen a substantial increase in patients served.

16 Regulations All Medical Directors in the OASAS system much be buprenorphine authorized All new Medical Directors have 4 years to become AAAP, ASAM or AOA Addiction certified

17 Create new treatment capacity OASAS repurposed capital appropriations and in April 2013 made capital project awards to build two 25 bed Young Adult/Adolescent Treatment programs o o Horizon Village in Western NY Outreach in LI Both awards are in process

18 Adolescent TA Grant Marc Fishman MD (Baltimore) 2 day meeting to produce guidance document Clear that a strategy was needed and not just detox o Use of Vivitrol or other blockers while engaged in treatment

19 Comprehensive Psychiatric Emergency Program (CPEP) and Emergency Departments An important component of treatment for the prescription drug misuser. OASAS presented at several OMH Comprehensive Psychiatric Emergency Program (CPEP) and Psychiatric Emergency Department meetings in order to familiarize the groups with the OASAS Provider system and how to make referrals. For the Emergency Departments we established July 2013 as Partnership Month for our programs to introduce themselves to Emergency Departments. The 2 nd phase of the Partnership Campaign was a reminder in called TAKE THE FIRST STEP where we sent out an OASAS HOPELINE flyer/poster to all the providers which will allow them to enter their contact info on the flyer. We had over 100 programs participating statewide.

20 Narcan Overdose Prevention We trained over 1000 which included patients, families, police, sheriffs, physicians, school nurses, EMTs to name a few. o Have your local police been trained? August 31 st, NYS OD Prevention Day All ATCs gave community training on overdose prevention the week of August 31, 2013

21 NYCDOHMH We worked with NYCDOHMH on proper dosing guidelines

22 What can we do next?

23 Narcan Overdose Prevention Expand the program to include: o o o o o o School nurses College Dorm RA s Club Security College Security First responders Prisoners on release (UK program: N-ALIVE)

24 Education Toolkits for schools PSAs for TV and radio in targeted markets. Prescriber education recommendation Continue to educate parents that treatment and not detox is needed

25 Possible New Regulations Check I-STOP as a part of each admission assessment Narcan to be available on every shift in an OASAS program

26 Reducing Prescription Drug Misuse Through the Use of a Citizen Mail-Back Program as in Maine VA program since 2008, now in 47 states

27 Why Did They Do This and What We Don t Know Why did FDA approve Zyhydro? Why did the FDA approve Ambien for mid-night awakening? Will I-STOP limit availability and drive users to heroin?

28

New Initiatives to Expand Access to Medication Assisted Treatment in NYS OASAS

New Initiatives to Expand Access to Medication Assisted Treatment in NYS OASAS New Initiatives to Expand Access to Medication Assisted Treatment in NYS OASAS Charles W. Morgan, MD, DFASAM, FAAFP Medical Director New York State Office of Alcoholism and Substance Abuse Services February

More information

NYS Responses to Opioid Use

NYS Responses to Opioid Use NYS Responses to Opioid Use Charles W. Morgan, MD, DFASAM, FAAFP Medical Director Belinda M. Greenfield, Ph.D. Bureau Director, Adult Treatment Services NY State Opioid Treatment Authority (SOTA) Oversees

More information

OPIOID WORKGROUP LEADERSHIP TEAM

OPIOID WORKGROUP LEADERSHIP TEAM OPIOID WORKGROUP LEADERSHIP TEAM Community-wide Action Plan and Call to Action This brief summary of the Opioid Action Plan presented to the Skagit County Board of Health on December 13, 2016 provides

More information

Performance of North Carolina's System for Monitoring Prescription Drug Abuse. Session Law , Section 12F.16.(q)

Performance of North Carolina's System for Monitoring Prescription Drug Abuse. Session Law , Section 12F.16.(q) Performance of North Carolina's System for Monitoring Prescription Drug Abuse Session Law 2015-241, Section 12F.16.(q) Report to the Joint Legislative Oversight Committee on Health and Human Services and

More information

MANAGING THE COSTS OF THE OPIOID EPIDEMIC IN WISCONSIN. State Senator Alberta Darling

MANAGING THE COSTS OF THE OPIOID EPIDEMIC IN WISCONSIN. State Senator Alberta Darling MANAGING THE COSTS OF THE OPIOID EPIDEMIC IN WISCONSIN State Senator Alberta Darling A NATIONAL PROBLEM According to the 2014 National Survey on Drug Use and Health: 435,000 Americans have used heroin

More information

The Future of Prevention: Addressing the Prescription Drug Abuse and the Opioid/Heroin Epidemic in our Country

The Future of Prevention: Addressing the Prescription Drug Abuse and the Opioid/Heroin Epidemic in our Country Integrating Primary and Behavioral Health Care Through the Lens of Prevention July 14, 2016 New Orleans, Louisiana The Future of Prevention: Addressing the Prescription Drug Abuse and the Opioid/Heroin

More information

Opioid Abuse in Iowa Rx to Heroin. Iowa Governor s Office of Drug Control Policy January 2016

Opioid Abuse in Iowa Rx to Heroin. Iowa Governor s Office of Drug Control Policy January 2016 1 Opioid Abuse in Iowa Rx to Heroin Iowa Governor s Office of Drug Control Policy January 2016 Why Is This Important? 2 3 National Rx Painkiller Trends CDC, 2013 4 National Rx-Heroin Trends NIH, 2015 5

More information

Evidence-Based Prevention Strategies in Wisconsin 101. Outline for This Session. Continuum of Care 6/8/2015

Evidence-Based Prevention Strategies in Wisconsin 101. Outline for This Session. Continuum of Care 6/8/2015 Evidence-Based Prevention Strategies in Wisconsin 101 Christine Niemuth, Prevention Coordinator Paul Krupski, Prevention Coordinator Division of Mental Health and Substance Abuse Services Bureau of Prevention

More information

Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD

Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse Pain, Pain Management and the Opioid Epidemic Symposium Jill M Williams, MD Professor Psychiatry Director, Division Addiction

More information

Massachusetts Responds to the Opioid Epidemic Using Data To Inform Policy and Programs. Monica Bharel, MD MPH Commissioner of Public Health

Massachusetts Responds to the Opioid Epidemic Using Data To Inform Policy and Programs. Monica Bharel, MD MPH Commissioner of Public Health Massachusetts Responds to the Opioid Epidemic Using Data To Inform Policy and Programs Monica Bharel, MD MPH Commissioner of Public Health Data For Massachusetts 2017 Q2 Quarterly Report and Chapter 55

More information

Michael M. Miller, MD, FASAM, FAPA

Michael M. Miller, MD, FASAM, FAPA Michael M. Miller, MD, FASAM, FAPA mmiller@rogershospital.org Medical Director, Herrington Recovery Center (HRC) Rogers Memorial Hospital Oconomowoc, Wisconsin Vice Speaker Wisconsin Medical Society Clinical

More information

YOUTH OPIOID ABUSE PREVENTION TOOLKIT

YOUTH OPIOID ABUSE PREVENTION TOOLKIT YOUTH OPIOID ABUSE PREVENTION TOOLKIT President Trump, the First Lady and the entire Trump Administration is committed to combatting the opioid crisis. The youth opioid abuse prevention campaign will be

More information

PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE

PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE September 20, 2013 Association of State and Territorial Health Officials Annual Meeting R. Gil Kerlikowske Director of National Drug Control Policy National

More information

Progress Report and 2018 Legislative Opportunities. Maine Opiate Collaborative Recommendations

Progress Report and 2018 Legislative Opportunities. Maine Opiate Collaborative Recommendations Progress Report and 2018 Legislative Opportunities related to the Maine Opiate Collaborative Recommendations April 2018 A. Destigmatize substance use disorders within the law enforcement profession 1.

More information

Spotlight on Health Policy Beyond the Clinical: The Opioid Epidemic. October 25, 2017

Spotlight on Health Policy Beyond the Clinical: The Opioid Epidemic. October 25, 2017 Spotlight on Health Policy Beyond the Clinical: The Opioid Epidemic October 25, 2017 Disclosures and Disclaimer Neither the Institute for Health Policy and Leadership (IHPL) nor I have any relevant financial

More information

Reduce Substance Abuse to Lowest Level in Vermont Increase Awareness of Treatment and Recovery Stronger Communication with Organizations Establish a

Reduce Substance Abuse to Lowest Level in Vermont Increase Awareness of Treatment and Recovery Stronger Communication with Organizations Establish a Reduce Substance Abuse to Lowest Level in Vermont Increase Awareness of Treatment and Recovery Stronger Communication with Organizations Establish a model Call-IN protocol Implement Evidence Based Programs

More information

Submitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis

Submitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis STATEMENT FOR THE RECORD Submitted to the House Energy and Commerce Committee Federal Efforts to Combat the Opioid Crisis October 25, 2017 America s Health Insurance Plans 601 Pennsylvania Avenue, NW Suite

More information

A Drug Policy for the 21st Century

A Drug Policy for the 21st Century A Drug Policy for the 21st Century June 18, 2013 2013 NASADAD/NPN/NTN Annual Meeting Michael Botticelli, Deputy Director White House Office of National Drug Control Policy National Drug Control Strategy

More information

Opioid Task Force Kick-Off Meeting. February 29, 2016

Opioid Task Force Kick-Off Meeting. February 29, 2016 Opioid Task Force Kick-Off Meeting February 29, 2016 Scope of the Opioid Problem and Data Review Olivia Kasirye, MD, MS County Public Health Officer OVERVIEW The Opioid Epidemic Opioid Task Force Development

More information

Why pay for Continuing Education when you can get it for FREE!?

Why pay for Continuing Education when you can get it for FREE!? Why pay for Continuing Education when you can get it for FREE!? Special Projects Coordinator Arizona Center for Rural Health 9/15/17 This publication was supported by the Grant Number 1U17CE002717-01,

More information

Taos Alive. Improving a Community in Pain By Julie Martinez CPS

Taos Alive. Improving a Community in Pain By Julie Martinez CPS Taos Alive Improving a Community in Pain By Julie Martinez CPS About Taos County About Taos Alive Community Based Coalition 12 Sectors (Youth, Parents, Business, Media, Schools, Youth Serving Organizations,

More information

Potential Solutions to Epidemic Substance Abuse in US and Europe

Potential Solutions to Epidemic Substance Abuse in US and Europe Potential Solutions to Epidemic Substance Abuse in US and Europe Richard C. Dart, MD, PhD Director, Rocky Mountain Poison and Drug Center, Denver Health 1 Professor, University of Colorado School of Medicine

More information

Whatcom County. Opioid Abuse. Prevention & Response Plan

Whatcom County. Opioid Abuse. Prevention & Response Plan Whatcom County Opioid Abuse Prevention & Response Plan Prepared by the Whatcom County Health Department on Behalf of Whatcom has HOPE March 2017 INTRODUCTION On September 6, 2016, twenty-seven stakeholders

More information

Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates

Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates What is MAT? Medication Assisted Treatment (MAT) is the use of medications, in addition to counseling, cognitive behavioral

More information

Strategic Plan

Strategic Plan 2017-18 Strategic Plan 1 Strategic Planning Process The Summit County Opiate Task Force has made great strides in addressing the opiate crisis in the last few years. More than 100 Summit County citizens

More information

From Medicaid Transformation Approved Project Toolkit, June 2017

From Medicaid Transformation Approved Project Toolkit, June 2017 From Medicaid Transformation Approved Project Toolkit, June 2017 Domain 3: Prevention and Health Promotion Transformation projects within this domain focus on prevention and health promotion to eliminate

More information

Mainstreaming naloxone rescue kits from harm reduction programs to pharmacies, police and fire responders

Mainstreaming naloxone rescue kits from harm reduction programs to pharmacies, police and fire responders Mainstreaming naloxone rescue kits from harm reduction programs to pharmacies, police and fire responders Alexander Y. Walley, MD, MSc Boston University School of Medicine ThINC Bergen 2015 Conference

More information

ACCG Mental Health Summit

ACCG Mental Health Summit ACCG Mental Health Summit Sheila Pierce, Opioid Program Coordinator Director, Prescription Drug Management Program Discussion 1. Overview Opioid Problem in GA - Video 2. DPH Opioid Program 3. Priorities

More information

Prescription Drug Abuse Task Force Rx Report Card

Prescription Drug Abuse Task Force Rx Report Card San Diego County Prescription Drug Abuse Task Force 2016 Rx Report Card October 2016 Key Measures of Prescription Drug and Heroin Problems in San Diego County. Visit www.sandiegorxabusetaskforce.org for

More information

THE FDA DRUG APPROVAL PROCESS Under the Federal Food, Drug, and Cosmetic (FD&C) Act, FDA is responsible for ensuring that all new drugs are safe and

THE FDA DRUG APPROVAL PROCESS Under the Federal Food, Drug, and Cosmetic (FD&C) Act, FDA is responsible for ensuring that all new drugs are safe and THE FDA DRUG APPROVAL PROCESS Under the Federal Food, Drug, and Cosmetic (FD&C) Act, FDA is responsible for ensuring that all new drugs are safe and effective. Before any drug is approved for marketing

More information

Agenda. 1 Opioid Addiction in the United States. Evidence-based treatments for OUD. OUD Treatment: Best Practices. 4 Groups: Our Model

Agenda. 1 Opioid Addiction in the United States. Evidence-based treatments for OUD. OUD Treatment: Best Practices. 4 Groups: Our Model Agenda 1 Opioid Addiction in the United States 2 Evidence-based treatments for OUD OUD Treatment: Best Practices 4 Groups: Our Model 2 Groups is a national network of clinics providing affordable, evidencebased

More information

OPIOID USE DISORDER AND THE PSYCHIATRIC EMERGENCY ROOM THE VA CT MODEL

OPIOID USE DISORDER AND THE PSYCHIATRIC EMERGENCY ROOM THE VA CT MODEL OPIOID USE DISORDER AND THE PSYCHIATRIC EMERGENCY ROOM THE VA CT MODEL Brian Fuehrlein, MD PhD VA Connecticut Healthcare System and Yale University I have no conflicts of interest or relevant financial

More information

Washington State s Overdose Epidemic

Washington State s Overdose Epidemic Caleb Banta-Green PhD MPH MSW Senior Research Scientist- Alcohol and Drug Abuse Institute Affiliate Associate Professor- School of Public Health Affiliate Faculty- Harborview Injury Prevention & Research

More information

Understanding the Opiate Epidemic

Understanding the Opiate Epidemic Understanding the Opiate Epidemic An opiate is a narcotic analgesic that depresses the central nervous system. Natural opiates are derived from the poppy plant. Synthetic opiates are manufactured drugs

More information

PORT GAMBLE S KLALLAM TRIBE. Tribal Opioid Response Plan

PORT GAMBLE S KLALLAM TRIBE. Tribal Opioid Response Plan PORT GAMBLE S KLALLAM TRIBE Tribal Opioid Response Plan Rate per 100,000 40 35 30 Rates of Opioid Overdose Deaths by Race/Ethnicity, WA State 2011-2015 34.4 2 25 20 15 10 12.4 12.3 15.1 5 0 1.1 1.2 1 White

More information

Fred Podesta, Department of Finance and Administrative Services Director Catherine Lester, Human Services Department Director

Fred Podesta, Department of Finance and Administrative Services Director Catherine Lester, Human Services Department Director MEMORANDUM DATE: TO: VIA: FROM: Subject: Councilmember Teresa Mosqueda, Chair Housing, Health, Energy, and Workers Rights Ben Noble, Budget Director Fred Podesta, Department of Finance and Administrative

More information

Using Structured Frameworks to Implement Opioid Use Disorder (OUD) Prevention Approaches. Melissa Struzzo, MPH

Using Structured Frameworks to Implement Opioid Use Disorder (OUD) Prevention Approaches. Melissa Struzzo, MPH Using Structured Frameworks to Implement Opioid Use Disorder (OUD) Prevention Approaches Melissa Struzzo, MPH Learning Objectives To identify ways to engage the community coalition in collaboration with

More information

EXECUTIVE ORDER TAKING FURTHER ACTIONS TO ADDRESS THE OPIOID OVERDOSE CRISIS

EXECUTIVE ORDER TAKING FURTHER ACTIONS TO ADDRESS THE OPIOID OVERDOSE CRISIS EXECUTIVE ORDER TAKING FURTHER ACTIONS TO ADDRESS THE OPIOID OVERDOSE CRISIS Gina M. Raimondo, Governor Nicole Alexander-Scott, MD, MPH, Director of Health Action Plan Strategies to Date Since 2015, we

More information

What does it mean? What can we do?

What does it mean? What can we do? PRESCRIPTION DRUG ABUSE IN ST. CLAIR COUNTY: What does it mean? What can we do? Annual Insurance Symposium May 8, 2013 Annette Mercatante MD, MPH Medical Health Officer St. Clair County Health Department

More information

Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention

Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention The Accountable Community for Health of King County Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention May 7, 2018 1 Opiate Treatment & Overdose Prevention Project Goal Immediate:

More information

State Opioid Response (SOR) Grant

State Opioid Response (SOR) Grant State Opioid Response (SOR) Grant Adam Bucon, LSW DMHAS Provider Meeting September 20, 2018 Philip D. Murphy Governor Shereef M. Elnahal Commissioner Sheila Y. Oliver Lt. Governor NJ Opioid Statistics

More information

Trends and Challenges: The Kentucky Opioid Crisis. Jason Smith, MD PhD University of Louisville

Trends and Challenges: The Kentucky Opioid Crisis. Jason Smith, MD PhD University of Louisville Trends and Challenges: The Kentucky Opioid Crisis Jason Smith, MD PhD University of Louisville Brief Introduction I am by no means an expert I have no financial disclosures Jokes are meant to be lighthearted

More information

Opioids: Public Health Crisis Local Solutions: National Epidemic

Opioids: Public Health Crisis Local Solutions: National Epidemic Opioids: Public Health Crisis Local Solutions: National Epidemic Nancy McGraw, LCSW, MBA Public Health Director Sullivan County Public Health Services 50 Community Lane Liberty, NY 12754 Luis Alvarez,

More information

Combating Opiate Addiction

Combating Opiate Addiction Combating Opiate Addiction Patrick E Keefe Chief of Police July 2015 Statement of the Problem The recent heroin epidemic has spared no community or law enforcement agency. The wide availability of heroin

More information

2004-L SEPTEMBER

2004-L SEPTEMBER BULLETIN INTELLIGENCE Buprenorphine: Potential for Abuse Product No. 2004-L0424-013 SEPTEMBER 2004 U. S. D E P A R T M E N T O F J U S T I C E NDIC Within the past 2 years buprenorphine a Schedule III

More information

SULLIVAN COUNTY Drug Abuse Prevention Task Force

SULLIVAN COUNTY Drug Abuse Prevention Task Force SULLIVAN COUNTY Drug Abuse Prevention Task Force Joseph A. Todora LMSW, Commissioner Sullivan County Division of Health ans Family Servies 17 Community Lane Liberty, NY 12754 MISSION: The mission of the

More information

A Community Response to a Community Crisis

A Community Response to a Community Crisis A Community Response to a Community Crisis Prevention Intervention Treatment Recovery Factors that Affect Health Public Health Pyramid Smallest Impact Largest Impact Counseling and Education Clinical Interventions

More information

BERNALILLO COUNTY OPIOID ABUSE ACCOUNTABILITY SUMMIT Turning the Curve on Opioid Abuse in Bernalillo County

BERNALILLO COUNTY OPIOID ABUSE ACCOUNTABILITY SUMMIT Turning the Curve on Opioid Abuse in Bernalillo County BERNALILLO COUNTY OPIOID ABUSE ACCOUNTABILITY SUMMIT Turning the Curve on Opioid Abuse in Bernalillo County NMPHA Annual Conference April 2, 2014 Marsha McMurray-Avila Coordinator, Bernalillo County Community

More information

Prescription Drug Abuse and Heroin: Impact on Oregon s Youth and Young Adults

Prescription Drug Abuse and Heroin: Impact on Oregon s Youth and Young Adults North Coast Opioid Summit Prescription Drug Abuse and Heroin: Impact on Oregon s Youth and Young Adults April 28, 2016 The Oregon Epidemic Oregon ranks #2 in Non-Medical Use of Opioids, 5% of population

More information

Mission. To increase awareness among county residents of heroin and prescription drug abuse and the devastating effects on our community

Mission. To increase awareness among county residents of heroin and prescription drug abuse and the devastating effects on our community Mission To increase awareness among county residents of heroin and prescription drug abuse and the devastating effects on our community Goals Help to reduce the demand for and availability of heroin and

More information

Mapping Opioid and Other Drug Issues (MOODI) Tool. Washington State Category 3 Grant BJA Meeting August 2016

Mapping Opioid and Other Drug Issues (MOODI) Tool. Washington State Category 3 Grant BJA Meeting August 2016 Mapping Opioid and Other Drug Issues (MOODI) Tool Washington State Category 3 Grant BJA Meeting August 2016 MOODI A statewide GIS mapping tool that integrates PDMP and other opioid-related datasets to

More information

2017 PARTNERSHIP FOR A DRUG-FREE NEW JERSEY (PDFNJ) STUDY

2017 PARTNERSHIP FOR A DRUG-FREE NEW JERSEY (PDFNJ) STUDY Itzhak Yanovitzky, Ph.D. Associate Professor Department of Communication School of Communication and Information Rutgers, The State University of New Jersey 4 Huntington Street, New Brunswick, NJ 08901

More information

PRESCRIPTION MONITORING PROGRAM

PRESCRIPTION MONITORING PROGRAM State of Connecticut Department of Consumer Protection PRESCRIPTION MONITORING PROGRAM CONNECTICUT S OUTREACH AND EDUCATIONAL EFFORTS Prescription Monitoring Program Prescribers & Pharmacists: How to Access

More information

ALLEGANY COUNTY HEROIN & OPIOID ABUSE AD HOC COMMITTEE March 9, 2017 NOT APPROVED

ALLEGANY COUNTY HEROIN & OPIOID ABUSE AD HOC COMMITTEE March 9, 2017 NOT APPROVED ALLEGANY COUNTY HEROIN & OPIOID ABUSE AD HOC COMMITTEE NOT APPROVED Committee Members Present: J. Hopkins (Chairman), L. Ballengee, V. Grant, K. LaForge, W. Penman, B. Riehle, (Absent: M. Biddle, A. Bucholz,

More information

But like others, we were initially fighting pill mills. Orange County worked to outlaw them and to provide resources for breaking opioid addiction.

But like others, we were initially fighting pill mills. Orange County worked to outlaw them and to provide resources for breaking opioid addiction. U.S. House of Representatives Committee on Oversight and Government Reform Witness Testimony by Orange County, Florida Mayor Teresa Jacobs FINAL Remarks as Prepared 668 words (5 minutes) Tuesday, March

More information

PDMP Track: Linking and Mapping PDMP Data. Gillian Leichtling Acumentra Health Chris Baumgartner, WA State Dept. of Health

PDMP Track: Linking and Mapping PDMP Data. Gillian Leichtling Acumentra Health Chris Baumgartner, WA State Dept. of Health PDMP Track: Linking and Mapping PDMP Data Gillian Leichtling Acumentra Health Chris Baumgartner, WA State Dept. of Health Disclosure Statement Gillian Leichtling and Chris Baumgartner have disclosed no

More information

Medication Assisted Treatment: Right for you, Right for your Recovery? Robert Matylewicz, DO, FASAM Medical Director, Clarity Way Inc.

Medication Assisted Treatment: Right for you, Right for your Recovery? Robert Matylewicz, DO, FASAM Medical Director, Clarity Way Inc. Medication Assisted Treatment: Right for you, Right for your Recovery? Robert Matylewicz, DO, FASAM Medical Director, Clarity Way Inc. Elements Behavioral Health Diplomate, American Board of Addiction

More information

Kentucky All Schedule Prescription Electronic Reporting (KASPER)

Kentucky All Schedule Prescription Electronic Reporting (KASPER) Kentucky All Schedule Prescription Electronic Reporting (KASPER) Phyllis Millspaugh Manager, Behavioral Health Prevention and Promotion Kentucky Cabinet for Health and Family Services Using PDMP Data to

More information

Building a Comprehensive, Community-driven Prevention Approach to the Opioid Crisis in Maine

Building a Comprehensive, Community-driven Prevention Approach to the Opioid Crisis in Maine Building a Comprehensive, Community-driven Prevention Approach to the Opioid Crisis in Maine Scott M. Gagnon, MPP, PS-C Director, AdCare Educational Institute of Maine, Inc. Co-Chair, Prevention & Harm

More information

Overcoming the Substance Abuse Epidemic: One Member at a Time

Overcoming the Substance Abuse Epidemic: One Member at a Time Overcoming the Substance Abuse Epidemic: One Member at a Time Innovation and Partnerships: our keys to success Sosunmolu Shoyinka, M.D., FAPA Medical Director for Substance Use Disorders, Centene Corporation.

More information

Chronic Pain Management in the Primary Care Setting

Chronic Pain Management in the Primary Care Setting Chronic Pain Management in the Primary Care Setting Keeping you and your patients safe. Joel Porter, MD October 1, 2015 Chronic Pain Management Chronic pain is a major public health problem Existing chronic

More information

Mission: The Oregon Coalition for Responsible Use of Meds (OrCRM) is a Statewide Coalition launched to prevent overdose, misuse and abuse of

Mission: The Oregon Coalition for Responsible Use of Meds (OrCRM) is a Statewide Coalition launched to prevent overdose, misuse and abuse of Mission: The Oregon Coalition for Responsible Use of Meds (OrCRM) is a Statewide Coalition launched to prevent overdose, misuse and abuse of amphetamines and opioids, both prescription and illicit, among

More information

the Opioid Epidemic: Montgomery County s Response Age No-Doz Age Zantac Age 0 4 Amoxicillin Age 4 12 Ritalin Age Prozac

the Opioid Epidemic: Montgomery County s Response Age No-Doz Age Zantac Age 0 4 Amoxicillin Age 4 12 Ritalin Age Prozac the Opioid Epidemic: Montgomery County s Response Age 0 4 Amoxicillin Age 4 12 Ritalin Age 12 18 Appetite Suppressants Age 18 24 No-Doz Age 24 38 Prozac Age 38 65 Zantac 65 1 Everything Else Learnings

More information

VIRGINIA S OPIOID & HEROIN OVERDOSE EPIDEMIC

VIRGINIA S OPIOID & HEROIN OVERDOSE EPIDEMIC 1 VIRGINIA S OPIOID & HEROIN OVERDOSE EPIDEMIC Virginia Association of Counties November 14, 2016 The Honorable William A. Hazel, Jr., M.D. Secretary of Health and Human Resources 1999 - Estimated drug

More information

Buprenorphine Prescribing as a Patient- Centered Medical Home Enhancement

Buprenorphine Prescribing as a Patient- Centered Medical Home Enhancement Buprenorphine Prescribing as a Patient- Centered Medical Home Enhancement TANNER NISSLY DO, BOB LEVY MD FASAM, MICHELE MANDRICH MSW, CMPE AS YOU ENTER, PLEASE SET UP TO PARTICIPATE IN OUR POLL EVERYWHERE

More information

Implementing Pain and Opioid Management Guidelines in Primary Care Practice

Implementing Pain and Opioid Management Guidelines in Primary Care Practice Implementing Pain and Opioid Management Guidelines in Primary Care Practice Objectives 1. What is the issue? 2. Why use a dedicated dissemination & implementation process? a. Historical perspective Cooperative

More information

Blue Cross of Idaho Addresses State s Opioid Issue

Blue Cross of Idaho Addresses State s Opioid Issue Blue Cross of Idaho Addresses State s Opioid Issue BY THE NUMBERS - Opioid Management page 3 THE PROBLEM - How Preventing Pain Hurt Us page 4 THE SOLUTIONS - Idaho State Board Of Pharmacy Prescription

More information

SC MAT ACCESS. Medication Assisted Treatment Academic Community Capacity Expansion for Sustainable Success Kathleen Brady, MD, PhD, VPR, MUSC

SC MAT ACCESS. Medication Assisted Treatment Academic Community Capacity Expansion for Sustainable Success Kathleen Brady, MD, PhD, VPR, MUSC SC MAT ACCESS Medication Assisted Treatment Academic Community Capacity Expansion for Sustainable Success Kathleen Brady, MD, PhD, VPR, MUSC Overdose Death Rates from Opiates Most important sign of a

More information

Creating a Structure for Success: Humboldt Opioid Safety Coalition. Mary Meengs, MD, Medical Director Rosemary DenOuden, Chief Operating Officer

Creating a Structure for Success: Humboldt Opioid Safety Coalition. Mary Meengs, MD, Medical Director Rosemary DenOuden, Chief Operating Officer Creating a Structure for Success: Humboldt Opioid Safety Coalition Mary Meengs, MD, Medical Director Rosemary DenOuden, Chief Operating Officer Behind the Redwood Curtain Remote, sparsely populated 135K

More information

Good Samaritan. State with this law in place: New Mexico, Washington, New York, Connecticut, Illinois (to be enforced June 1, 2012)

Good Samaritan. State with this law in place: New Mexico, Washington, New York, Connecticut, Illinois (to be enforced June 1, 2012) Good Samaritan Immunity Laws that provide protection from prosecution for calling 911 if seeking medical attention for self or another experiencing an overdose The US Conference of Mayors 2008 unanimously

More information

Opioid Use and Misuse: History, Trends, And The Oregon Opioid Initiative

Opioid Use and Misuse: History, Trends, And The Oregon Opioid Initiative Opioid Use and Misuse: History, Trends, And The Oregon Opioid Initiative John W. McIlveen, Ph.D., LMHC, State Opioid Treatment Authority, Oregon Health Authority, Addictions and Mental Health Division

More information

Changing Course: statewide efforts to combat the opioid epidemic in California

Changing Course: statewide efforts to combat the opioid epidemic in California Changing Course: statewide efforts to combat the opioid epidemic in California Kelly Pfeifer, MD kpfeifer@chcf.org April 26, 2018 State of Reform conference STAT Special Report: 52 weeks, 52 faces Obituaries

More information

Substance Use Disorders: A Path Forward for Michigan

Substance Use Disorders: A Path Forward for Michigan Substance Use Disorders: A Path Forward for Michigan DEBRA A. PINALS, M.D. MEDICAL DIRECTOR BEHAVIORAL HEALTH AND FORENSIC PROGRAMS MICHIGAN DEPARTMENT OF HEALTH AND HUMAN SERVICES Tackling the opiate

More information

Meth and Opioid Abuse Prevention Efforts

Meth and Opioid Abuse Prevention Efforts Meth and Opioid Abuse Prevention Efforts Prescription Drugs/Opioids in South Dakota Departments of Health and Social Services Drug Abuse in South Dakota South Dakota ranked 2 nd lowest in the nation for

More information

Aligning Pain Management Community Public Health Presentation

Aligning Pain Management Community Public Health Presentation Aligning Pain Management Community Public Health Presentation Al Bliss, Health Educator La Crosse County Health Department 2016 Project Goal: (Community Public Health Session) Aligning Pain Care in Our

More information

Dutchess County Substance Abuse Prevention Initiative

Dutchess County Substance Abuse Prevention Initiative Dutchess County Substance Abuse Prevention Initiative Prevention Agenda Priority Promote Mental Health and Prevent Substance Abuse Latham, NY Wednesday, November 12, 2014 Background Justification: a) Mortality

More information

HOPE Agenda. Heroin, Opioid Prevention & Education WISCONSIN STATE REPRESENTATIVE JOHN NYGREN ASSEMBLY DISTRICT 89

HOPE Agenda. Heroin, Opioid Prevention & Education WISCONSIN STATE REPRESENTATIVE JOHN NYGREN ASSEMBLY DISTRICT 89 HOPE Agenda Heroin, Opioid Prevention & Education WISCONSIN STATE REPRESENTATIVE JOHN NYGREN ASSEMBLY DISTRICT 89 In compliance with CMA regulation, I attest that I have no conflicts of interest associated

More information

Presenters. Session Objectives. Session Overview. Cluster Investigations in Rural Wisconsin

Presenters. Session Objectives. Session Overview. Cluster Investigations in Rural Wisconsin Public Health Nurses, Hepatitis C, Injection Drug Use and Heroin Sheila Guilfoyle Viral Hepatitis Prevention Coordinator Division of Public Health Wisconsin Department of Health Services Wisconsin Public

More information

Orange County Heroin Task Force Update

Orange County Heroin Task Force Update Health Services Department Orange County Heroin Task Force Update June 28, 2016 Presentation Outline Heroin Problem Orange County Heroin Task Force Review of Task Force Recommendations Advisory Committee

More information

BALTIMORE S RESPONSE TO THE OVERDOSE EPIDEMIC: AN OPEN SOCIETY INSTITUTE-BALTIMORE BRIEF

BALTIMORE S RESPONSE TO THE OVERDOSE EPIDEMIC: AN OPEN SOCIETY INSTITUTE-BALTIMORE BRIEF BALTIMORE S RESPONSE TO THE OVERDOSE EPIDEMIC: AN OPEN SOCIETY INSTITUTE-BALTIMORE BRIEF Introduction Dr. Leana Wen, Baltimore City Health Commissioner O pioid drug overdose is an epidemic and a public

More information

OXYCONTIN Diversion & Abuse Drug Enforcement Administration Office of Diversion Control October 2003

OXYCONTIN Diversion & Abuse Drug Enforcement Administration Office of Diversion Control October 2003 OXYCONTIN Diversion & Abuse Office of Diversion Control October 2003 OXYCONTIN OxyContin is a controlled release form of Schedule II oxycodone Manufactured in tablet form and intended for oral ingestion

More information

Table of Contents Interim Report of the OxyContin Task Force, Newfoundland & Labrador, January 30, 2004

Table of Contents Interim Report of the OxyContin Task Force, Newfoundland & Labrador, January 30, 2004 OXYCONTIN TASK FORCE INTERIM REPORT January 30, 2004 Submitted to Hon. Elizabeth Marshall, Minister of Health & Community Services, Government of Newfoundland and Labrador Table of Contents INTRODUCTION

More information

Data Driven Strategies

Data Driven Strategies Data Driven Strategies Full Task Force Meeting September 16, 2014 Review the problems Snapshot of local data Task Force goals Risk factors Breakout groups Prevention Intervention Treatment Recovery Words

More information

TESTIMONY Of Pam Gehlmann Executive Director/ Assistant Regional Director Pinnacle Treatment Centers Alliance Medical Services-Johnstown

TESTIMONY Of Pam Gehlmann Executive Director/ Assistant Regional Director Pinnacle Treatment Centers Alliance Medical Services-Johnstown TESTIMONY Of Pam Gehlmann Executive Director/ Assistant Regional Director Pinnacle Treatment Centers Alliance Medical Services-Johnstown Center for Rural Pennsylvania On Confronting the Heroin Epidemic

More information

Care in the Face of the Opioid Epidemic: How Yale University and Yale New Haven Hospital are Reaching Underserved Communities

Care in the Face of the Opioid Epidemic: How Yale University and Yale New Haven Hospital are Reaching Underserved Communities Care in the Face of the Opioid Epidemic: How Yale University and Yale New Haven Hospital are Reaching Underserved Communities Jeanette M. Tetrault, MD FACP FASAM Associate Professor of Medicine Program

More information

Anyone Can Become Addicted. Anyone.

Anyone Can Become Addicted. Anyone. Anyone Can Become Addicted. Anyone. PAStop.org Family Toolkit Seeking Drug Abuse Treatment: Know What to Ask Trying to identify the right treatment programs for a loved one can be a difficult process.

More information

A BluePrint for Ohio s Community Mental Health and Addiction System

A BluePrint for Ohio s Community Mental Health and Addiction System A BluePrint for Ohio s Community Mental Health and Addiction System Ohio s Opiate Epidemic In 2010, for the first time overdoses accounted for more deaths than traffic accidents. This trend has continued

More information

Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction

Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny, MD Co-Director, Opioid Policy Research Collaborative Heller School for Social Policy and Management Brandeis

More information

State of Connecticut Department of Mental Health and Addiction Services. State Innovations in Prevention and Treatment of Opioid Use Disorders

State of Connecticut Department of Mental Health and Addiction Services. State Innovations in Prevention and Treatment of Opioid Use Disorders State of Connecticut Department of Mental Health and Addiction Services State Innovations in Prevention and Treatment of Opioid Use Disorders National Academy for State Health Policy October 23, 2017 ~

More information

Battling Opioid Addiction: Public Policy and Healthcare Strategies for an Epidemic

Battling Opioid Addiction: Public Policy and Healthcare Strategies for an Epidemic Battling Opioid Addiction: Public Policy and Healthcare Strategies for an Epidemic Speakers: Margarita Pereyda, M.D., Principal, Moderator: Carl Mercurio, Information Services September 29, 2015 HealthManagement.com

More information

Combating the Opiate Crisis in Ohio

Combating the Opiate Crisis in Ohio Combating the Opiate Crisis in Ohio In 2011, Gov. John R. Kasich announced the establishment of the Governor s Cabinet Opiate Action Team to fight opiate abuse in Ohio. Ohio is combating drug abuse through

More information

Wisconsin s Opioid Crisis. Grape Vine Conference June 19th, 2018

Wisconsin s Opioid Crisis. Grape Vine Conference June 19th, 2018 Wisconsin s Opioid Crisis Grape Vine Conference June 19th, 2018 Federal Grants to Address Opioid Crisis Wisconsin Department of Health Services Division of Care and Treatment Services Grant Titles Medication-Assisted

More information

EMERGENCY DEPARTMENT MODEL PRACTICES DEALING WITH THE PRESCRIPTION OPIOID EPIDEMIC

EMERGENCY DEPARTMENT MODEL PRACTICES DEALING WITH THE PRESCRIPTION OPIOID EPIDEMIC EMERGENCY DEPARTMENT MODEL PRACTICES DEALING WITH THE PRESCRIPTION OPIOID EPIDEMIC RAMI R KHOURY, MD, FACEP ASSISTANT MEDICAL DIRECTOR EMERGENCY CARE ALLEGIANCE HEALTH ADVERTISING AT ITS BEST! OVERDOSE

More information

Saving Lives and Treating Addiction in Baltimore City

Saving Lives and Treating Addiction in Baltimore City Saving Lives and Treating Addiction in Baltimore City Mark O Brien Director of Opioid Overdose Prevention and Treatment Evan Behrle Special Assistant to the Health Commissioner Catherine E. Pugh Mayor,

More information

The National Association of State Alcohol and Drug Abuse Directors (NASADAD) FY 2018 Appropriations

The National Association of State Alcohol and Drug Abuse Directors (NASADAD) FY 2018 Appropriations The National Association of State Alcohol and Drug Abuse Directors (NASADAD) FY 2018 Appropriations March 2018 Update On March 23 rd, 2018, President Donald Trump signed a fiscal year 2018 (October 1,

More information

SEPA Regional Overdose Prevention Coalition. Breaking Down Silos

SEPA Regional Overdose Prevention Coalition. Breaking Down Silos SEPA Regional Overdose Prevention Coalition Breaking Down Silos David A. McKeighan Executive Director Chester & Delaware County Medical Societies Chester County Overdose Task Force Delaware County Heroin

More information

Opioid Use Disorders &Medication Treatment

Opioid Use Disorders &Medication Treatment Agency medical director comments Opioid Use Disorders &Medication Treatment Charissa Fotinos, MD, MSc Deputy Chief Medical Officer Washington State Health Care Authority Learning Objectives: 1) Review

More information

The Challenge of Treating Pain

The Challenge of Treating Pain FDA Charge to the Committee: FDA Opioid Action Plan and Incorporating the Broader Public Health Impact into the Formal Risk-Benefit Assessment for Opioids Robert M. Califf, MD Commissioner of Food and

More information

State Action to Prevent and

State Action to Prevent and State Action to Prevent and Treat Prescription Drug Abuse Paul Jarris, MD, MBA Executive Director Association of State and Territorial Health Officials Hearing from Each Other: State Reports NGA Policy

More information

Prescription Drug Take-Back Program Q s and A s

Prescription Drug Take-Back Program Q s and A s Got Drugs? Prescription Drug Take-Back Program Q s and A s What is the national drug take-back day? On Saturday, September 25 from 10:00 a.m. to 2:00 p.m., DEA and partner organizations will set up sites

More information